BIO-TECHNE Corp - COMMON STOCK (TECH)

Historical Holders from Q3 2014 to Q3 2025

Symbol
TECH on Nasdaq
Type / Class
Equity / COMMON STOCK
Shares outstanding
152M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
159M
Holdings value
$8.84B
% of all portfolios
0.012%
Grand Portfolio weight change
+0%
Number of holders
562
Number of buys
302
Number of sells
-251
Average Value change %
0%
Average buys %
+0.002%
Average sells %
-0.005%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BIO-TECHNE Corp - COMMON STOCK (TECH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7% $567M 11M BlackRock, Inc. 30 Jun 2025
PRICE T ROWE ASSOCIATES INC /MD/ 2.2% -56.7% $186M -$306M 3.35M -62.1% T. Rowe Price Associates, Inc. 30 Sep 2025

Institutional Holders of BIO-TECHNE Corp - COMMON STOCK (TECH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 159M $8.84B +$43.8M $55.63 562
2025 Q2 159M $8.16B -$122M $51.45 549
2025 Q1 160M $9.41B +$179M $58.63 570
2024 Q4 157M $11.3B +$66.8M $72.03 570
2024 Q3 155M $12.4B +$7.43M $79.93 556
2024 Q2 156M $11.2B -$178M $71.65 567
2024 Q1 159M $11.2B +$202M $70.39 546
2023 Q4 155M $12B +$252M $77.16 525
2023 Q3 152M $10.4B +$40.4M $68.07 522
2023 Q2 151M $12.3B +$213M $81.63 521
2023 Q1 149M $11B -$125M $74.19 542
2022 Q4 150M $12.5B +$9.25B $82.88 536
2022 Q3 38.1M $10.8B +$194M $284.00 520
2022 Q2 37.2M $12.9B -$180M $346.64 534
2022 Q1 37.7M $16.3B +$325M $433.04 546
2021 Q4 36.9M $19.1B -$21.6M $517.34 560
2021 Q3 36.7M $17.8B +$72.2M $484.57 556
2021 Q2 36.6M $16.5B +$204M $450.26 504
2021 Q1 36.5M $13.9B +$173M $381.93 460
2020 Q4 36.2M $11.5B -$16.8M $317.55 426
2020 Q3 36.3M $8.98B -$42.9M $247.73 409
2020 Q2 36.4M $9.6B -$81.5M $264.07 384
2020 Q1 36.8M $6.99B +$119M $189.62 357
2019 Q4 35.8M $7.85B -$46M $219.51 366
2019 Q3 36M $7.04B +$117M $195.67 333
2019 Q2 35.4M $7.38B +$61.9M $208.49 362
2019 Q1 35.5M $7.06B +$61.4M $198.55 347
2018 Q4 35.4M $5.12B -$123M $144.72 316
2018 Q3 35.8M $7.31B +$15.7M $204.11 335
2018 Q2 36M $5.33B +$35.7M $147.95 333
2018 Q1 35.9M $5.42B -$28.5M $151.04 325
2017 Q4 36.4M $4.71B -$46.7M $129.55 288
2017 Q3 36.9M $4.46B -$52.5M $120.89 282
2017 Q2 37.3M $4.38B +$215M $117.50 272
2017 Q1 36.5M $3.71B +$392M $101.65 265
2016 Q4 35.9M $3.7B +$12.7M $102.83 270
2016 Q3 35.8M $3.92B -$133M $109.50 279
2016 Q2 37.1M $4.18B -$54.3M $112.77 278
2016 Q1 37.6M $3.55B +$20.3M $94.52 251
2015 Q4 37.4M $3.36B +$85.9M $90.00 258
2015 Q3 36.3M $3.36B -$28.6M $92.46 245
2015 Q2 36.7M $3.62B +$4.05M $98.47 238
2015 Q1 36.5M $3.66B +$67.7M $100.29 243
2014 Q4 36.1M $3.33B +$2.87B $92.40 252
2014 Q3 4.95M $463M +$463M $93.55 24